Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy.

Pediatrics

Volumn 110, Issue 5, 2002, Pages

  Lainka, Elke ^a   Oezbek, Selda ^a   Falck, Manfred ^a   Ndagijimana, Jennifer ^a   Niehues, Tim ^a  

^a Children's Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

AMBULATORY CARE; ARTICLE; BLOOD; CARBOHYDRATE DIET; CHEMICALLY INDUCED DISORDER; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DRUG COMBINATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MALE; METABOLISM; METHODOLOGY; STATISTICS;

AMBULATORY CARE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CROSS-SECTIONAL STUDIES; DIETARY CARBOHYDRATES; DRUG THERAPY, COMBINATION; FASTING; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; MALE; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 18844470226     PISSN: None     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.110.5.e56     Document Type: Article

References (0)